MeSH tree: D12.125.072.050.685
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people with the disease more control over their movements.
Oct 29, 2025
0
47
A research team from the University of Cologne conducted one of the most comprehensive studies on dopamine and decision-making in humans so far, providing evidence for effects of the former on the latter. Dopamine is a neurotransmitter ...
Oct 28, 2025
0
26
Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment interventions. In a new eNeuro paper, Daniil Berezhnoi, from Georgetown University, and colleagues used ...
Jul 28, 2025
0
14
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets.
Jul 11, 2025
0
39
Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to treat Parkinson's disease.
Jun 26, 2025
0
47
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with fat.
Jun 24, 2025
0
21
Including dairy in your diet may help control blood sugar levels better than a plant-only diet, a new study has found.
May 13, 2025
0
24
For patients with Parkinson's disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time versus placebo, according to a ...
Apr 8, 2025
0
33
Brought into the limelight by actor Michael J. Fox, Parkinson's disease affects the body's ability to control movement.
Apr 7, 2025
0
23
A study from Emory University suggests that levodopa, a medication that increases dopamine levels in the brain, may help treat individuals with depression who experience motivational impairments due to high inflammation. ...
Mar 20, 2025
0
52
